Population Health Research Institute ^Institute

Recent work: Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial (ACT COVID19). The ACT COVID-19 program consists of two parallel trials evaluating treatments for COVID-19 in outpatients and inpatients who have tested positive for COVID-19. In the outpatient study, the combination of chloroquine with azithromycin will be evaluated to see if this treatment can prevent deterioration leading to hospital admission. For inpatients, the combination of chloroquine with azithromycin, as well as interferon beta-1b, will be evaluated to see if it can prevent admission to intensive care, mechanical ventilation and/or death.